Effect of flosteron on the content of acute-phase proteins and procalcitonin in infectious arthritis in rats
S.М. Маgомеdоv1, Yu.V. Polyachenko1, N.P. Hrystai1, I.G. Lytovka2, V.I. Sabadash1, Т.А. Кuzub1, L.V. Polishchuk1
- Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
- O.O.Bogomoletz Institute of Physiology of the National Academy of Sciences of Ukraine, Kyiv, Ukraine
Infectious arthritis was modeled on white male Wistar rats by injecting a suspension of Staphylococcus aureus
microorganisms into the knee joint of animals, and the effects of the synthetic hormone flosteron were also
studied. At the same time, the content of acute-phase proteins (ceruloplasmin, haptoglobin, C-reactive protein
(CRP)) and procalcitonin (PCT) as markers of the development of the inflammatory process and bacterial
infection was studied in the blood serum of rats. Determination of the content of haptoglobin, ceruloplasmin and
CRP was carried out on a Cobas 311 biochemical analyzer, the PCT concentration on a Cobas 411 analyzer
using Roche Diagnostics test systems. Analysis of the results showed that when flosteron was administered,
the concentration of CRP increased by 1.7 times already on the 3rd day, and by more than 4 times on the 14th
day. The content of ceruloplasmin and haptoglobin also increased. The PCT concentration was at the level
of the control values. Under the conditions of modeling infectious arthritis, changes in the content of acutephase proteins were observed. The greatest deviations from the reference values were found on the 14th day in
animals that were injected with the hormone and S. aureus: the concentration of both CRP, the most objective
biochemical marker of the inflammatory process, and PCT exceeded the physiological norm 12 times and
more than 7 times, respectively. This indicates that the hormonal drug enhances the inflammatory process,
which is confirmed by data that reflect changes in the content of acute-phase proteins. It can be assumed that
the use of hormonal drugs contributes to the development of postoperative complications.
infectious arthritis; Staphylococcus aureus; flosteron; rats
- Velkov VV. Procalcitonin and C-reactive protein in modern laboratory diagnostics. Clin Lab Consult. Part 1, 2008;25(6):46-52. [Russian].
- Magomedov AM, Gerasimenko SI, Boychuk BP, Krinitskaya OF, Kravchenko EN, Arshulik MA. Metabolism of acute-phase proteins in patients with trauma of the lower extremities long bones. Bull Ortop Traumatol Prosthet. 2014;1:24-8. [Russian].
- Bukhanova DV, Belov BS, Tarasova GM, Dilbaryan AG. Procalcitonin test in rheumatology. Clinician. 2017;11(2):16-23. [Russian].
- Lapin SV, Maslyansky AL, Lazareva NM, Vasilyeva EYu, Totolyan AA. The value of the quantitative determination of procalcitonin for the diagnosis of septic complications in patients with autoimmune rheumatic diseases. Clin Lab Diagnost. 2013;1:28-33. [Russian].
- Shen CJ, Wu MS, Lin KH, et al. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32(6):807-14.
- Magomedov S, Kravchenko OM, Kolov GB, Shevchuk AV. Procalcitonin as a biochemical marker in the diagnosis of inflammatory processes (literature review). Bull Ortoped Traumat Prosthet. 2018;1:63-7. [Ukrainian].
- Fuchs T, Stange R, Schmidmaier G, Raschke MJ. The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch Orthoped Trauma Surg. 2011;131(10):1419-25.
- Wallbach M, Vasko R, Hoffmann S, et al. Elevated procalcitonin levels in a severe lupus flare without infection. Lupus. 2016;25(14):1625-6.
- Magomedov AM, Polishchuk LV, Kuzub TA, Kolov GB, Gordiy AS. Metabolism of connective tissue in patients with purulent complications after osteosynthesis of fragments of long bones. Trauma. 2016;17(1):111-15. [Russian].
- Jevsevar DS, Brown GA, Jones DL, Matzkin EG, Manner PA, et al. The American Academy of Orthopedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J Bone Joint Surg Am. 2013 Oct 16;95(20):1885-6.
- Bedard NA, DeMik DE, Glass NA, Burnett RA, Bozic KJ, Callaghan JJ. Impact of clinical practice guidelines on use of intra-articular hyaluronic acid and corticosteroid injections for knee osteoarthritis. J Bone Joint Surg Am. 2018 May 16;100(10):827-34.
- Tsujimoto K, Hata A, Fujita M, Hatachi S, Yagita M. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis. Int J Rheumat Dis. 2018 Jul;21(7):1406-13.